Norbert Pardi | Assistant Professor
University of Pennsylvania
Dr. Norbert Pardi holds a Ph.D. in biochemistry and genetics. He has been working at the University of Pennsylvania since 2011 and currently holds an Assistant Professor position. His research interest is the development of mRNA-based therapeutics with particular focus on new generation vaccines. He explored the development of a novel protein delivery platform using nucleoside-modified mRNA in lipid nanoparticles (LNPs) and used it to generate highly effective mRNA-LNP vaccines targeting various pathogens. Dr. Pardi has recently been involved in the development of highly effective vaccine adjuvants.
Appearances:
Pre-congress Workshops, April 6 @ 2:00
WORKSHOP F (CONTINUED): ADJUVANTS
Presentations include:- Perspectives of vaccine adjuvant discovery and development, and funding opportunities for adjuvant research
- Optimal approaches for clinical evaluation of Small Molecule Immune Potentiators
- Adjuvants that specifically drive immune responses required for challenging vaccines
- TB
- Next Generation Saponin Adjuvants for Improved Vaccines
- Influenza: Identification of new adjuvants inducing potent and durable humoral immune responses
last published: 05/Mar/20 10:35 GMT
Sign Up for Event Updates
Organiser
